MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease

HK. Na, CW. Park, Y. Sun, JH. Lee, YY. Choi, SJ. Chung, YH. Sohn, CH. Lyoo, PH. Lee (Seodaemun-gu, Republic of Korea)

Meeting: 2025 International Congress

Keywords: Dopaminergic neurons, Gait disorders: Pathophysiology, Parkinson’s

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: To explore the potential contribution of dopamine loss, perfusion deficit, and cognition to spatiotemporal gait parameters in patients with Parkinson’s disease (PD).

Background: Gait disturbance is one of the debilitating symptoms of PD, significantly impacting quality of life and prognosis. Gait impairment is not solely determined by dopamine depletion but characterized by a complex interplay of dopaminergic deficits, cerebral metabolism, and cognition. However, the relationship between these factors remains unclear. Dual-phase 18F-FP-CIT positron emission tomography (PET) provides both striatal dopamine transporter (DAT) availability (delayed phase) and perfusion imaging (early phase), thus serving as an attractive modality to investigate the neural correlates of gait parameters in PD.

Method: In this retrospective study, we included 150 drug-naïve patients with PD who underwent dual-phase 18F-FP-CIT PET, neuropsychological assessments, and quantitative gait analysis using GAITRite system. Multivariate linear regression analyses were performed to identify the potential determinants of spatiotemporal gait parameters derived from self-paced walking, which were adjusted for age, sex, motor phenotype and white matter hyperintensity.

Results: Caudate DAT availability revealed positive correlation with stride length and cadence, while step time difference was associated with the asymmetry index in the putamen. Functional ambulation profile (FAP) score and gait velocity revealed significant positive correlation with DAT availability in the caudate nucleus and cerebral perfusion in prefrontal and inferior parietal regions, and performance in attention and frontal/executive domains. Path analyses revealed that the influence of the frontoparietal hypoperfusion on gait disturbance (gait velocity and FAP) were mediated by frontal/executive dysfunction. In a serial mediation analysis model incorporating the DAT availability, perfusion, cognition, and gait parameters, the influence of caudate DAT availability on FAP score and gait velocity was completely mediated by prefrontal hypoperfusion and frontal/executive dysfunction.

Conclusion: Our findings demonstrate that dopaminergic loss in the caudate nucleus, altered cerebral perfusion in frontoparietal association cortices, and cognitive performance in the frontal/executive domain may serve as neural substrates underlying gait disturbance in PD.

To cite this abstract in AMA style:

HK. Na, CW. Park, Y. Sun, JH. Lee, YY. Choi, SJ. Chung, YH. Sohn, CH. Lyoo, PH. Lee. Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/contribution-of-dopamine-depletion-cerebral-perfusion-and-cognition-to-gait-dysfunction-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/contribution-of-dopamine-depletion-cerebral-perfusion-and-cognition-to-gait-dysfunction-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley